AZD1283

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

AZD1283 is an effective P2Y12 receptor antagonist (EC50: 3.0 ug/kg/min, binding IC50: 11 nM).

AZD1283 is a potent antagonist of the P2Y12 receptor. In a modified Folts model in dog, both AZD1283 dose-dependently induced increases in blood flow and inhibition of ADP-induced platelet aggregation with antithrombotic ED50 values of 3.0 μg/kg/min. The doses that induced a larger than 3-fold increase in bleeding time were 33 μg/kg/min. Thus, the therapeutic index (TI) was ≥ 10. On the basis of these data, AZD1283 was progressed into human clinical trials as candidate drug.

AZD-1283; AZD1283; AZD 1283

Angiogenesis

PDE

P2Y12

Cardiovascular Disease

——

919351-41-0

470.54

C23H26N4O5S

98%

DMSO : 100 mg/mL. 212.52 mM;H2O : < 0.1 mg/mL

CCOC(=O)c1c(nc(c(c1)C#N)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1)C

ethyl 6-(4-((benzylsulfonyl)carbamoyl)piperidin-1-yl)-5-cyano-2-methylnicotinate.

(-20℃)

With Ice Pack

≥ 2 years